Virtus ETF Advisers LLC Intellia Therapeutics, Inc. Transaction History

Virtus ETF Advisers LLC

$206 Million
Q3 2024

A detailed history of Virtus ETF Advisers LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 3,550 shares of NTLA stock, worth $46,611. This represents 0.04% of its overall portfolio holdings.

Number of Shares

3,550

Previous 3,487 1.81%

Holding current value

$46,611

Previous $78,000 7.69%

% of portfolio

0.04%

Previous 0.04%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$19.72 - $27.36 $1,242 - $1,723	63 Added 1.81%	3,550 $72,000
Q2 2024 Aug 14, 2024	BUY	$20.02 - $27.22 $15,375 - $20,904	768 Added 28.25%	3,487 $78,000
Q1 2024 May 15, 2024	SELL	$23.82 - $32.8 $4,454 - $6,133	-187 Reduced 6.43%	2,719 $74,000
Q4 2023 Feb 15, 2024	BUY	$23.16 - $32.34 $16,536 - $23,090	714 Added 32.57%	2,906 $88,000
Q3 2023 Nov 07, 2023	SELL	$31.62 - $45.78 $6,766 - $9,796	-214 Reduced 8.89%	2,192 $69,000
Q2 2023 Aug 14, 2023	SELL	$34.58 - $46.03 $7,054 - $9,390	-204 Reduced 7.82%	2,406 $98,000
Q1 2023 May 15, 2023	SELL	$33.3 - $44.82 $33,300 - $44,820	-1,000 Reduced 27.7%	2,610 $97,000
Q4 2022 Feb 14, 2023	BUY	$33.21 - $62.69 $29,556 - $55,794	890 Added 32.72%	3,610 $125,000
Q3 2022 Nov 14, 2022	BUY	$53.92 - $71.7 $1,401 - $1,864	26 Added 0.97%	2,720 $152,000
Q2 2022 Aug 12, 2022	BUY	$38.49 - $76.21 $51,615 - $102,197	1,341 Added 99.11%	2,694 $139,000
Q1 2022 May 16, 2022	SELL	$58.27 - $118.99 $4,195 - $8,567	-72 Reduced 5.05%	1,353 $98,000
Q4 2021 Feb 14, 2022	SELL	$100.76 - $138.36 $100,155 - $137,529	-994 Reduced 41.09%	1,425 $168,000
Q3 2021 Nov 15, 2021	SELL	$132.37 - $176.78 $16,281 - $21,743	-123 Reduced 4.84%	2,419 $325,000
Q2 2021 Aug 10, 2021	SELL	$60.88 - $161.91 $195,972 - $521,188	-3,219 Reduced 55.88%	2,542 $412,000
Q1 2021 May 17, 2021	BUY	$46.59 - $83.68 $4,612 - $8,284	99 Added 1.75%	5,761 $462,000
Q4 2020 Feb 12, 2021	SELL	$18.83 - $63.53 $193,289 - $652,135	-10,265 Reduced 64.45%	5,662 $308,000
Q3 2020 Nov 13, 2020	SELL	$17.47 - $24.93 $37,962 - $54,172	-2,173 Reduced 12.01%	15,927 $317,000
Q2 2020 Aug 05, 2020	BUY	$11.14 - $22.87 $201,634 - $413,947	18,100 New	18,100 $380,000

Others Institutions Holding NTLA

# of Institutions

314

Shares Held

91.5M

Call Options Held

442K

Put Options Held

880K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $998M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account

Virtus ETF Advisers LLC Intellia Therapeutics, Inc. Transaction History